Medivir AB announces license agreement with Daewoong Pharmaceutical for MIV-210 drug
Medivir AB (Sweden) today announced a license agreement with Daewoong Pharmaceutical Co. Ltd., (South Korea) for its hepatitis B virus (HBV) polymerase inhibitor drug, lagociclovir valactate (MIV-210).
- admin's blog
- Login or register to post comments
- Feed: news-medical.net-disease-news
- Original article
Yahoo! BOSS
No related items were found.
Yahoo! BOSS Images
No related items were found.
